An investigation on behalf of investors in CryoLife, Inc. (NYSE: CRY) shares over potential wrongdoing at CryoLife, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 06/16/2020 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors at CryoLife, Inc.
Investors who purchased shares of CryoLife, Inc. (NYSE: CRY) shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain CryoLife, directors breached their fiduciary duties and caused damage to the company and its shareholders.
Kennesaw, GA based CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. CryoLife, Inc. reported that its annual Total Revenue rose from $262.84 million in 2018 to $276.22 million in 2019 and that its Net Loss of $2.84 million In 2018 turned into a Net Income of $1.7 million in 2019.
Shares of CryoLife, Inc. (NYSE: CRY) declined from $31.77 per share on January 29, 2020, to as low as $12.63 per share on March 23, 2020.
Those who purchased shares of CryoLife, Inc. (NYSE: CRY) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.